Another reason starting glp-1 supplement programs feels urgent is the accountability built into TrimRx services
10.1056/NEJMoa1509225 77 PsichasA.SleethM
Moreover, peptide analogues that are unimolecular co-agonists of both GLP-1R and GCGR are currently in clinical development for the treatment of T2D, obesity and non-alcoholic steatohepatitis (NASH) 2,3,5,6,7
Clinical data shows Mounjaro produces up to 22.5% body weight reduction compared to Victozas roughly 3%
Unlike older single-mechanism weight loss drugs, Retatrutide is engineered as a triagonist meaning it simultaneously activates three key metabolic receptors: glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors
At 12 mg per week, one vial lasts just under 2 weeks